Tag Archives: ACA

Harvard Launches New Campaign to End Insurance Discrimination

Be.Futureproof

Earlier this year, BIO launched our Value Campaign. One of the main goals of this effort is to shine a spotlight on the insurance industry’s efforts to restrict patients’ access to the medications they need. For years, the insurance industry and its allies have made patients pay more for less coverage. That’s just plain wrong. In the post-Affordable Care Act (ACA) age, insurers—banned from  excluding patients with pre-existing conditions—have taken to more creative means to Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Correcting the Record On Politico’s Misinformed Article

new-bio-logo

Politico recently explored the relationship between the biopharmaceutical industry and the Affordable Care Act (ACA). The article laments the supposed high cost of drugs and implicitly endorses policies that would not only do little for patients in need of medications, but also stifle innovation through research and development. The implication that the “structural reforms” the story talks about would fundamentally change drug costs in this country is myopic and misinformed. Those so-called “reforms” like top-down, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Urges States to Use CMS Grants to Combat Discrimination by Health Plans

new-bio-logo

On June 15, the Centers for Medicare and Medicaid Services (CMS) announced $22 million in Affordable Care Act (ACA) funding for state insurance departments.  The Agency’s announcement noted that States are meant to utilize the funding to ensure that plans comply with “key consumer protections,” listing among them: essential health benefits, preventive services, parity in mental health and substance use disorder benefits, appeals processes, and bringing down the cost of health care coverage (also known Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

NYTimes Reports Insurers are Struggling, Their Own Data Says Otherwise

health care, medicine

The New York Times’ Reed Abelson yesterday reported on the plight of insurers who are supposedly losing money thanks to the Affordable Care Act (ACA) and asks the existential question: “Can insurance companies run a viable business in the individual market?” In short, yes. More broadly, most insurers are not just “viable.” They are thriving. Despite what insurance companies may say in print, the financial data paints a different picture. In the age of the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Exchange Plans are Helping Patients, But Challenges Remain

Session

After describing many of the benefits the Exchanges have brought to patients—including access to both coverage and federal subsidies—the moderator for the 2014 BIO International Convention breakout session, Impact of Exchanges for Patients, tasked panelists representing a diverse group of stakeholders to describe the challenges that remain for patients enrolled in Exchange plans. These challenges fell into four main categories, including: formulary depth, patient out-of-pocket costs, transparency, and provider networks. In terms of formulary depth, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,